Placeholder

Late Phase Market Overview and Outlook (2010)

$6,800.00 – $10,200.00

Licensing Options

  • SINGLE-USER LICENSE

    A Single-User License allows access to an individual user.

  • ENTERPRISE-WIDE LICENSE

    An Enterprise-Wide License allows access to all employees and sites within an organization.

Ask us about our library subscription plans

Report Overview

Q1, 2010

This study is based on interviews with 149 decision-makers from around the world representing 95 unique pharma and biotech companies.

Respondents discuss, in detail, their plans for study conduct and outsourcing across various Late Phase study categories. In addition, respondents provide their perceptions of – and experiences with – dozens of Late Phase service providers. The report contains 153 pages, including novel and insightful analyses and nearly 200 charts and graphs.

 

What you will learn:

  • Late Phase market size and growth potential
  • Late Phase service provider service quality and customer loyalty
  • What drives sponsors’ selection of Late Phase service providers
  • What drives sponsors’ satisfaction with Late Phase service delivery
  • The complex decision-making units within sponsor companies
  • Growth and decline in study conduct and outsourcing
  • ePRO and Electronic Health Record Trends
  • Innovation in Late Phase
  • Service Providers Leading in Late Phase
  • Service Provider Usage
  • Service Provider Quality / Performance
  • Service Provider Loyalty
  • Drivers for late phase study conduct
  • Sponsors’ Departmental responsibilities
  • Service Provider selection by study type

 

Report Contents:

  1. Late Phase Trends and Market Sizing
  2. Service Provider Dynamics
  3. Decision Making for Late Phase Studies

Questions?

Our team is here to help.

For questions about syndicated report purchases, custom research solutions, or other billing-related topics, please contact sales@ISRreports.com.

Related products